Phil Tracy, Final President of BW USA

Date:
30 Apr 2001
Reference:
WF/M/AV/O/02/11
Part of:
Wellcome Foundation Ltd
  • Archives and manuscripts

About this work

Description

**Please note there is no release form associated with this interview.**

Tracy joined the first as a lawyer in 1974, coming from a law firm. He became General Counsel in 1981 and later President.

Topics covered include:

* legal department in 1970s

* general impressions of the company in the 1970s

* Fred Coe, Ted Haigler, Bill Sullivan and their varying management styles

* relationship between UK and US companies

* corporate structure, McKinsey Report

* comparison of UK and US businesses

* relationship with FDA

* generic drugs

* Wellbutrin

* Aids and Retrovir: pricing and the Waxman Congressional Inquiry

* Flotation

* John Robb

* relations with the Wellcome Trust

* merger with Glaxo

* BW Fund

* Zovirax and Empirin

Publication/Creation

30 Apr 2001

Physical description

2 audio tapes and transcript Tape 13

Copyright note

Copyright remains the property of interviewee.

Terms of use

This item is closed and cannot be accessed. Please see our Access Policy for more details. Closed until 1 January 2053.

Where to find it

  • LocationStatusAccess
    Closed stores
    WF/M/AV/O/02/11:Box 1
    ClosedCan't be requested

Permanent link